Skip to main content
Caplight Logo









AMS Planning

AMS Planning

Private
TokyoMedia, Entertainment & Gaminghttps://ams-plan.com/

Last Round

Private Equity

May 30, 2025

Total Funding Raised

$2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AMS Planning is a drug discovery company that develops nuclear medicine technologies designed to transform Japan's healthcare infrastructure by advancing clinical innovation and operational efficiency.

Sector

Media, Entertainment & Gaming

Verticals

Event Management, Business Intelligence, Facility Management

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Data as a Service

AI Layer

Non-AI

Keywords

arts and culture consultingfacility planningstrategic planningnon-profit consultingbusiness planningvenue planningentertainment industry consultingfinancial modelingperformance benchmarkingarts analyticscultural planningcommunity engagementorganizational developmentexecutive searchpublic policy consulting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AMS Planning Comparables

Compare AMS Planning with similar companies based on industry and business-model similarity.

AMS Planning comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Huron Consulting Group
52%

AMS Planning Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityMay 30, 2025
Series ANov 9, 2022

AMS Planning Investors

Notable investors and investment history

AMS Planning investors
InvestorRounds
MIRAISOZO INVESTMENTS Inc.Series A, Private Equity
Vision Incubate Co., Ltd.Private Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 436% MoM, reaching 831.

  • May 16, 2026

    Monthly visitors grew 291% MoM, reaching 1.1K.

AMS Planning Filings

Explore SEC and related filing metadata, where available.

AMS Planning filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AMS Planning's valuation, stock price, and market status.

Is AMS Planning a public or private company?

AMS Planning is a private company.

What is the current stock price of AMS Planning?

AMS Planning is a private company with no public stock price. No recent secondary market data is available.

How much is AMS Planning worth (valuation)?

Valuation information for AMS Planning is not publicly available.

Can I buy AMS Planning stock?

AMS Planning shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AMS Planning's last funding round?

AMS Planning's most recent funding round was Private Equity on May 30, 2025.

Who are the main investors in AMS Planning?

Key investors in AMS Planning include MIRAISOZO INVESTMENTS Inc..

Will AMS Planning IPO soon?

No public IPO plans have been announced for AMS Planning.

How can I track AMS Planning secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AMS Planning's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTokyo
Employee Range5
Year Founded2019
Last FundingMay 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?